Redcare Pharmacy NV (RDC.DE)
EUR 139.9
(-3.38%)
EUR 139.9
(-3.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 58.26 Million | -29.11 Million | 11.63 Million | 17.8 Million | -30.36 Million | -23.54 Million |
| Net Income | -12.04 Million | -69.17 Million | -65.69 Million | -866 Thousand | -33.44 Million | -28.73 Million |
| Depreciation & Amortization | 57.28 Million | 39.51 Million | 26.96 Million | 16.06 Million | 14.86 Million | 13.17 Million |
| Deferred income taxes | -103.67 Million | - | - | - | - | - |
| Stock-based compensation | 8.99 Million | 16.22 Million | 20.54 Million | 4.4 Million | 2.96 Million | 1.45 Million |
| Change in working capital | 13.49 Million | -16.98 Million | 28.51 Million | -1.23 Million | -14.72 Million | -9.42 Million |
| Other non-cash items | 94.19 Million | 1.3 Million | 1.3 Million | -564 Thousand | -25 Thousand | -6000.00 |
| Investing Cash Flow | -69.02 Million | -138 Million | -84.29 Million | -40.25 Million | -33.4 Million | -38.14 Million |
| Investments in PPE | -38.22 Million | -53.52 Million | -43.15 Million | -53.33 Million | -14.74 Million | -11.85 Million |
| Acquisitions | -23.44 Million | -6.01 Million | -31.18 Million | - | - | -4.37 Million |
| Investment purchases | -41.12 Million | -80.49 Million | -29 Million | - | -18.65 Million | -21.91 Million |
| Sales/Maturities of investments | 33.76 Million | -39.34 Million | 2.41 Million | 13.07 Million | - | 9.05 Million |
| Other Investing Activities | 4.23 Million | 41.37 Million | 16.63 Million | -1.92 Million | -29.39 Million | -9.05 Million |
| Financing Cash Flow | 23.06 Million | -13.51 Million | 229.59 Million | 50.28 Million | 102.08 Million | 65.3 Million |
| Debt repayment | -1.66 Million | -1.62 Million | -5.66 Million | -10.12 Million | -55.03 Million | -70.17 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 32.03 Million | 637 Thousand | 12.21 Million | 75.73 Million | 49.14 Million | - |
| Other Financing Activities | -7.3 Million | -12.52 Million | 223.03 Million | -15.32 Million | 107.96 Million | 65.3 Million |
| Accounts receivables | -20.31 Million | -2.27 Million | -6.58 Million | -3.69 Million | -7.31 Million | -5.17 Million |
| Accounts payables | 56.81 Million | -12.24 Million | 26.5 Million | 27.01 Million | 5.92 Million | 5.42 Million |
| Inventory | -16.59 Million | -3.08 Million | -15.37 Million | -24.55 Million | -13.33 Million | 128 Thousand |
| Other working capital | -6.4 Million | 625 Thousand | 23.96 Million | 5.93 Million | - | -9.55 Million |
| Cash at beginning of period | 66.77 Million | 247.41 Million | 90.48 Million | 62.65 Million | 24.33 Million | 10.92 Million |
| Cash at end of period | 84.16 Million | 66.77 Million | 247.41 Million | 90.48 Million | 62.65 Million | 14.53 Million |
| Capital Expenditure | -38.22 Million | -53.52 Million | -43.15 Million | -53.33 Million | -14.74 Million | -11.85 Million |
| Effect of forex changes on cash | 844 Thousand | - | - | 1000.00 | 1000.00 | -1000.00 |
| Net cash flow / Change in cash | 17.38 Million | -180.63 Million | 156.92 Million | 27.83 Million | 38.31 Million | 3.61 Million |
| Free Cash Flow | 20.04 Million | -82.63 Million | -31.52 Million | -35.53 Million | -45.1 Million | -35.39 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.26 Million | -7.8 Million | -12.04 Million | -5.58 Million | -2.01 Million | -2.23 Million |
| Depreciation & Amortization | 17.07 Million | 16.31 Million | 57.28 Million | 18.59 Million | 13.73 Million | 12.81 Million |
| Deferred income taxes | - | - | -103.67 Million | -50.14 Million | - | - |
| Stock-based compensation | 875 Thousand | 881 Thousand | 8.99 Million | 2.21 Million | 2.49 Million | 1.51 Million |
| Change in working capital | 13.1 Million | 9.92 Million | 13.49 Million | -21.72 Million | -22.75 Million | 21.18 Million |
| Other non-cash items | 14.1 Million | 28.16 Million | 94.19 Million | 47.55 Million | 908 Thousand | -32 Thousand |
| Investing Cash Flow | -10.64 Million | -9.71 Million | -69.02 Million | -57.77 Million | 31.84 Million | -26.82 Million |
| Investments in PPE | -10.39 Million | -9.59 Million | -38.22 Million | -11.77 Million | -8.55 Million | -8.73 Million |
| Acquisitions | - | - | -23.44 Million | 1000.00 | - | -23.44 Million |
| Investment purchases | -252 Thousand | -118 Thousand | -41.12 Million | -41 Million | -5000.00 | -113 Thousand |
| Sales/Maturities of investments | - | - | 33.76 Million | -4.98 Million | - | 23.55 Million |
| Other Investing Activities | -1000.00 | 7.05 Million | 4.23 Million | -2000.00 | 40.4 Million | -18.08 Million |
| Financing Cash Flow | -5.04 Million | -1.64 Million | 23.06 Million | -1.57 Million | -2.64 Million | 25.43 Million |
| Debt repayment | -618 Thousand | -406 Thousand | -1.66 Million | -638 Thousand | -124 Thousand | -498 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 648 Thousand | 731 Thousand | 32.03 Million | 1.06 Million | 1.31 Million | 29.55 Million |
| Other Financing Activities | -3.05 Million | -1.71 Million | -7.3 Million | -2 Million | -3.83 Million | -3.62 Million |
| Accounts receivables | 4.83 Million | -647 Thousand | -20.31 Million | 2.85 Million | -10.88 Million | -11.46 Million |
| Accounts payables | 15.64 Million | 5.95 Million | 56.81 Million | -6.93 Million | -2.64 Million | 39.34 Million |
| Inventory | 1.2 Million | 242 Thousand | -16.59 Million | -6.66 Million | -8.96 Million | -2.84 Million |
| Other working capital | -8.58 Million | 4.38 Million | -6.4 Million | -10.98 Million | -258 Thousand | -3.85 Million |
| Cash at beginning of period | 98.73 Million | 84.16 Million | 66.77 Million | 151.73 Million | 130.19 Million | 98.34 Million |
| Cash at end of period | 110.85 Million | 98.73 Million | 84.16 Million | 84.16 Million | 151.73 Million | 130.19 Million |
| Capital Expenditure | -10.39 Million | -9.59 Million | -38.22 Million | -11.77 Million | -8.55 Million | -8.73 Million |
| Effect of forex changes on cash | 268 Thousand | -645 Thousand | 844 Thousand | 869 Thousand | -32 Thousand | 8000.00 |
| Net cash flow / Change in cash | 12.11 Million | 14.57 Million | 17.38 Million | -67.57 Million | 21.53 Million | 31.85 Million |
| Free Cash Flow | 17.14 Million | 9.92 Million | 20.04 Million | -20.87 Million | -16.19 Million | 24.5 Million |
PSG
TCNAF
0267
STGYF
688030
AREBW